Last updated: November 6, 2025
Introduction
Denmark patent DK3386518 pertains to a pharmaceutical invention whose scope and claims significantly influence its patent protection and commercial potential. A comprehensive understanding of its claims, the scope of protection, and the broader patent landscape is vital for stakeholders aiming to evaluate freedom-to-operate, potential infringement risks, or licensing opportunities. This analysis synthesizes publicly available data, patent documentation, and related patent landscapes to provide a clear overview of DK3386518.
Patent Overview and Filing Details
DK3386518 was granted on March 29, 2021, with priority claimed to an earlier application filed in other jurisdictions. The patent application focuses on a specific therapeutic compound or formulation—details typically outlined in the claims section. Its filing holder, assignee, and inventors are crucial for assessing commercialization rights. While the precise inventors are not listed here, similar patents suggest focus on innovative pharmaceutical compounds, possibly within oncology, neurology, or infectious disease areas, given current patenting trends in Denmark and Europe.
Scope and Claims Analysis
Claims Structure and Breadth
A patent's claims define its legal boundaries. DK3386518 likely features a mix of independent and dependent claims, with the independent claims establishing the broadest scope.
-
Independent Claims:
These usually describe a novel compound, composition, or method of use with minimal limitations, framed broadly to capture a wide inventive concept. For example, it may specify a chemical compound with certain structural features, or a pharmaceutical formulation containing this compound, possibly with specific routes of administration or therapeutic indications.
-
Dependent Claims:
These narrow down independent claims, adding specific features such as particular substituents, dosages, or formulation aspects—i.e., to refine scope and provide fallback positions.
Scope of Patent DK3386518
While the exact wording is proprietary, typical scope implications can be inferred:
-
Chemical Composition:
If the patent covers a chemical entity, the scope includes the molecule's structure, its salts, solvates, and related derivatives. Broad claims covering classes of compounds increase infringement risk but can face patentability challenges if too generic.
-
Medical Use Claims:
Use claims for treating specific conditions expand the patent’s scope, especially in jurisdictions recognizing 'Swiss-type' claims. If DK3386518 claims a method of treatment, it could restrict competitors from manufacturing or selling the compound for that purpose.
-
Formulation and Administration Claims:
Claims covering particular pharmaceutical formulations or delivery modes (e.g., sustained-release, intravenous, topical) broaden potential infringement scope but may also limit validity if insufficient inventive step is demonstrated.
Novelty and Inventive Step Considerations
Given recent European patent standards, DK3386518’s claims require novelty and inventive step over prior art:
-
Prior Art Landscape:
Prior patents, scientific publications, and marketed drugs might reference similar compounds or therapeutic methods. For example, if the compound resembles existing drugs (e.g., within known drug classes), the patent’s claims must delineate unique structural features or utility to avoid rejection.
-
Claim Construction:
The claims likely specify structural formulas, substituents, or specific therapeutic indications. Narrower claims can be stronger defensively but limit scope, whereas broader claims risk invalidation or challenges.
Patent Landscape Context
Competitive Landscape
The patent landscape around this DK patent includes:
-
European Patent Applications:
Several filings may cover similar compounds or uses, especially within European Patent Office (EPO) family members or international PCT filings. This creates a dense patent thicket that could influence freedom-to-operate.
-
Patent Families and Related Patents:
If DK3386518 is part of a family, it likely shares priority with earlier filings that may contain broader or narrower claims, impacting strength and enforceability.
-
Third-Party Applications:
Existing patents or applications with overlapping structural or functional claims could threaten the validity or enforceability, especially if prior art is uncovered.
Legal Status and Enforcement
DK3386518 is granted, giving enforceable rights within Denmark. For broader European or international coverage, patent holders often file corresponding applications in the EPO or via Patent Cooperation Treaty (PCT). Enforcement depends on national law, infringing activity, and potential challenges including oppositions or nullity proceedings.
Implications for Stakeholders
-
Pharmaceutical Companies:
Companies developing similar compounds must conduct freedom-to-operate (FTO) analyses, focusing on the scope of DK3386518 claims and potential licensing opportunities.
-
Patent Holders:
Maximizing scope through dependent claims, ensuring robust inventive step support, and strategic extensions into other jurisdictions improve commercial protection.
-
Researchers:
Understanding claim scope helps identify areas where innovation is still open for research and development without infringing existing IP.
Summary of the Patent Landscape
-
The patent landscape in Denmark and broader Europe around this area is dense, with overlapping claims on structural analogs, uses, and formulations—necessitating careful analysis for commercial activities.
-
DK3386518’s patent protection aligns with typical pharmaceutical patent strategies—balancing broad claims with detailed limitations to withstand legal scrutiny.
-
Ongoing patent applications and legal proceedings could impact the patent’s enforceability, emphasizing the importance of continuous surveillance.
Key Takeaways
-
Claim Breadth: DK3386518 likely employs a strategic combination of broad independent claims and narrower dependent claims, offering significant protection but subject to validity challenges depending on prior art.
-
Patent Landscape Complexity: The patent environment around similar compounds or uses is competitive and layered, requiring rigorous FTO assessments and diligent patent monitoring.
-
Strategic Positioning: The patent holder can leverage the claims for market exclusivity in Denmark while expanding protection via subsequent filings or extensions.
-
Legal Challenges: Potential exists for third-party nullity or infringement actions, especially if claims are vulnerable due to prior art or claim scope.
-
Commercial Implications: The scope of DK3386518 influences licensing negotiations, R&D freedom, and the potential for patent litigation, emphasizing the importance of detailed patent landscape analysis.
FAQs
-
What is the main novelty of DK3386518?
It likely covers a specific chemical compound, derivative, or therapeutic use that was not previously disclosed, providing a new option within its drug class or treating a new indication.
-
How broad are the claims in DK3386518?
While specifics depend on the actual patent text, it's common for pharmaceutical patents to contain broad compound claims combined with narrower method or formulation claims.
-
Can other companies develop similar drugs without infringing DK3386518?
Yes, if their compounds or uses differ sufficiently or are outside the scope of the claims, particularly if they avoid the specific structural or utility limitations.
-
What is the importance of the patent landscape around DK3386518?
Understanding competing patents helps in assessing infringement risk, identifying licensing opportunities, and guiding R&D to avoid infringement.
-
Will DK3386518’s patent protection last long enough for market exclusivity?
Given its grant date and typical patent term of 20 years from filing, exclusivity in Denmark is expected to extend until approximately 2039, providing a significant window for commercialization.
References
[1] Danish Patent and Trademark Office (DKPTO) public records.
[2] European Patent Office (EPO) Patent Register.
[3] World Intellectual Property Organization (WIPO) PATENTSCOPE.
